2010
Ng TB, Wong JH, Wang H (2009) Recent Progress in Research on Ribosome Inactivating Proteins. Curr Protein Pept Sci 1323:94-108. (Targeting Trends 10q2)
2005
Wiley RG, Lappi DA (2005) Molecular Neurosurgery With Targeted Toxins. Humana Press Totowa, New Jersey. (Targeting Trends 05q3)
2004
Lappi DA, Wiley RG (2004) Immunotoxins and neuropeptide-toxin conjugates experimental applications. Mini Rev Med Chem 4(5):585-595. (Targeting Trends summary)
Parent MB, Baxter MG (2004) Septohippocampal acetylcholine: involved in but not necessary for learning and memory? Learn Mem 11:9-20. (Targeting Trends summary)
2003
Feldman JL, Mitchell GS, Nattie EE (2003) Breathing: Rhythmicity, Plasticity, Chemosensitivity. Annu Rev Neurosci 26:239-266. (Targeting Trends summary)
Madden CJ, Sved AF (2003) Rostral ventrolateral medulla C1 neurons and cardiovascular regulation. Cell Mol Neurobiol 23(4-5):739-749. (Targeting Trends summary)
Pappas BA, Sherren N (2003) Neonatal 192 IgG-saporin lesion of forebrain cholinergic neurons: focus on the life span? Neurosci Biobehav Rev 27(4):365-376. (Targeting Trends summary)
Wiley RG, Lappi DA (2003) Targeted toxins in pain. Adv Drug Deliv Rev 55(8):1043-1054. (Targeting Trends summary)
2001
Wiley RG (2001) Toxin-induced death of neurotrophin-sensitive neurons. (Review) Meth Mol Biol 169(1-2):217-222. (Targeting Trends summary)
2000
Gu Z, Wortwein G, Yu J, Perez-Polo JR (2000) Model for aging in the basal forebrain cholinergic system. (Review) Antiox Redox Signal 2(3):437-447. (Targeting Trends summary)
McGaughy J, Everitt BJ, Robbins TW, Sarter M (2000) The role of cortical cholinergic afferent projections in cognition: impact of new selective immunotoxins. Behav Brain Res 115:251-263.
Sarter M, Bruno JP, Miner LA, McGaughy J (2000) Development of a method for intraparenchymal infusions of 192 IgG-Saporin: a comment on Pizzo et al. (1999) [letter; comment] J Neurosci Methods 96:169-170.
Wiley RG (2000) Neuropeptide-toxin conjugates in pain research and treatment. (Review) Reg Anesth Pain Med 25(5):546-548.
1999
Detari L, Rasmusson DD, Semba K (1999) The role of basal forebrain neurons in tonic and phasic activation of the cerebral cortex. Prog Neurobiol 58:249-277.
Wiley RG (1999) Molecular Murder. Trends in Neurosci. 22(2):61.
1998
McDonald MP, Overmier JB (1998) Present Imperfect: A Critical Review of Animal Models of the Mnemonic Impairments in Alzheimer's Disease. Neurosci Biobehav Rev 22(1):99-120.
Rossner S (1998) Cholinergic immunolesions by 192 IgG-saporin--useful tool to simulate pathogenic aspects of Alzheimer's disease. Int J Dev Neurosci 15:835-850.
Wrenn CC, Wiley RG (1998) The behavioral functions of the cholinergic basal forebrain: lessons from 192 IgG-Saporin. Int J Dev Neurosci 16:595-602.
1997
Gallagher M (1997) Animal models of memory impairment. Philos Trans R Soc Lond [Biol] 352:1711-1717.
Picklo MJ (1997) Methods of sympathetic degeneration and alteration. J Auton Nerv Syst 62:111-125.
Wenk GL (1997) The nucleus basalis magnocellularis cholinergic system: one hundred years of progress. Neurobiol Learn Mem 67:85-95.
Wiley RG (1997) Findings about the cholinergic basal forebrain using immunotoxin to the nerve growth factor receptor. Ann N Y Acad Sci 835:20-29.
1996
Wiley RG (1996) Targeting toxins to neural antigens and receptors. Sem Cancer Biol 7:71-77.
1995
Gallagher M, Colombo PJ (1995) Ageing: the cholinergic hypothesis of cognitive decline. Curr Opin Neurobiol 5:161-168.
Picklo MJ, Wiley RG, Lonce S, Lappi DA, Robertson D (1995) Anti-dopamine b-hydroxylase immunotoxin induced sympathectomy in adult rats. J Pharmacol Exp Therap 275:1003-1010.
1994
Wiley RG, Lappi DA (1994) Suicide Transport and Immunolesioning (Houston: R.G. Landes).
1993
Contestabile A, Stirpe F (1993) Ribosome-inactivating proteins from plants as agents for suicide transport and immunolesioning in the nervous system. Eur J Neurosci 5:1292-1301.
1992
Wiley RG (1992) Neural lesioning with ribosome-inactivating proteins: suicide transport and immunolesioning. TINS 15:285-290.
